Price $6.10 |
Market Cap
366.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.63
|
P/S
162.05
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-45.4K
|
FCF
-1.0
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-29.60%
|
ROI
-26.50%
|
|
ROA
-27.00%
|
EPS Growth
59.90%
|
Current Ratio
18.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Sellas Life Sciences Group Inc (SLS) | $5.58 | - | - | 35.9M | Strong Buy |
| Alphatec Holdings Inc (ATEC) | $3.73 | - | - | 103.7M | Strong Buy |
| Premier Inc (PINC) | $32.22 | - | - | 4.5B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $21.23 | - | 4.80% | 17.38B | Strong Buy |
| Impax Laboratories Inc (IPXL) | $18.30 | - | - | 1.42B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
